1. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
- Author
-
Xiaohua Peng, Ian Leighton, Arnau Casanovas-Massana, Albert I. Ko, Santos Bermejo, Catharine M. Bosio, Charles S. Dela Cruz, Lokesh Sharma, Benjamin Schwarz, Yale Impact Team, Shelli F. Farhadian, Lydia M. Roberts, and Maksym Minasyan
- Subjects
Adult ,Male ,Immunology ,macromolecular substances ,Arachidonate 12-Lipoxygenase ,Article ,Proinflammatory cytokine ,03 medical and health sciences ,0302 clinical medicine ,Diabetes mellitus ,Humans ,Immunology and Allergy ,Medicine ,Aged ,Aged, 80 and over ,chemistry.chemical_classification ,Arachidonate 5-Lipoxygenase ,SARS-CoV-2 ,business.industry ,COVID-19 ,Lipid signaling ,Middle Aged ,Lipidome ,medicine.disease ,chemistry ,ALOX12 ,Eicosanoid ,Cyclooxygenase 2 ,Lipidomics ,Eicosanoids ,Female ,Docosanoid ,business ,Biomarkers ,030215 immunology ,Polyunsaturated fatty acid - Abstract
The COVID-19 pandemic has affected more than 20 million people worldwide, with mortality exceeding 800,000 patients. Risk factors associated with severe disease and mortality include advanced age, hypertension, diabetes, and obesity. Each of these risk factors pathologically disrupts the lipidome, including immunomodulatory eicosanoid and docosanoid lipid mediators (LMs). We hypothesized that dysregulation of LMs may be a defining feature of the severity of COVID-19. By examining LMs and polyunsaturated fatty acid precursor lipids in serum from hospitalized COVID-19 patients, we demonstrate that moderate and severe disease are separated by specific differences in abundance of immune-regulatory and proinflammatory LMs. This difference in LM balance corresponded with decreased LM products of ALOX12 and COX2 and an increase LMs products of ALOX5 and cytochrome p450. Given the important immune-regulatory role of LMs, these data provide mechanistic insight into an immuno-lipidomic imbalance in severe COVID-19.
- Published
- 2021
- Full Text
- View/download PDF